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ABSTRACT
The human DNA excision repair protein ERCC-1 exhibits homology to
the yeast RADIO repair protein and its longer C-terminus
displays similarity to parts of the E.coli repair proteins uvrA
and uvrC. To study the evolution of this 'mosaic' ERCC-1 gene we
have isolated the mouse homologue. Mouse ERCC-1 harbors the same
pattern of homology with RAD10 and has a comparable C-terminal
extension as its human equivalent. Mutation studies show that the
strongly conserved C-terminus is essential in contrast to the
less conserved N-terminus which is even dispensible. The mouse
ERCC-1 amino acid sequence is compatible with a previously
postulated nuclear location signal and DNA-binding domain. The
ERCC-1 promoter harbors a region which is highly conserved in
mouse and man. Since the ERCC-1 promoter is devoid of all
classical promoter elements this region may be responsible for
the low constitutive level of expression in all mouse tissues and
stages of embryogenesis examined
INTRODUCTION
Cell hybridization experiments have identified 6 complementation
groups within DNA excision repair deficient UV-sensitive Chinese
hamster ovary (CHO) cell lines (1-3). In many respects these
mutants resemble cells from the genetic disorder xeroderma
pigmentosum (XP) in which defects in at least nine genes (4,5)
underly the extreme sensitivity of XP patients to sun exposure
(UV light) and a predisposition to skin cancer. Cell fusion
studies - although incomplete - have thusfar not revealed any
overlap between these two classes of mutants (6). Hence, it is
possible that 15 or more genes play a role in the excision of UV
induced DNA damage in mammalian cells. Also in yeast and
prokaryotes many loci have been found to be implicated in
excision repair (see 7 for a review). In E.coli the uvrABC and D
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gene products play a key role in the excision repair machinery
and it is likely that comparable multiprotein complexes are
operative in higher organisms.
By applying genomic DNA transfer we have isolated the human
ERCC-1 gene which corrects the repair defect of UV and mitomycin-
C (MMC) sensitive CHO 43-3B cells belonging to complementation
group 1 ) (8). Recently, also the ERCC-2 gene complementing group
2*) mutants has been isolated (9). The ERCC-1 gene only corrects
CHO mutants of complementation group 1 (10) and restores all
impaired repair characteristics to wild type levels (11)
suggesting that ERCC-1 is the human homologue of the mutated gene
in CHO group 1 mutants.
Based on similarity of the predicted ERCC-1 amino acid sequence
with functional domains of other proteins, a putative nuclear
location signal (NLS), DNA binding domain and ADP-
monoribosylation site have been assigned to the ERCC-1 protein
(12). Furthermore, a significant homology with yeast RADIO and
parts of the E.coli uvrA and uvrC repair proteins has been found
(12-14). This suggests that DNA repair systems are well conserved
during evolution. In this respect it is worth noting that the
RAD6 protein which is involved in cellular response to DNA damage
in yeast and recently found to be a ubiquitin conjugating enzyme,
is also very strongly conserved up to mammals (15,16). The extent
of homology between ERCC-1 and RAD10 makes it tempting to
speculate that both proteins are functionally equivalent although
ERCC-1 has a C-terminal extension of 83 amino acids which is
absent in RAD10 (12). It is intriguing that this extra ERCC-1
part displays similarity with bacterial excision repair proteins.
It is possible that evolution has endowed ERCC-1 with functional
domains of distinct repair proteins in prokaryotes or that in
the course of evolution the tail of RADIO was lost. To
investigate these possibilities and to further establish the
significance of the postulated functional domains in the ERCC-1
protein, it is of interest to characterize the ERCC-1 gene of
other organisms. Here we report the characterization of the mouse
ERCC-1 gene and present mutation studies on the human ERCC-1
cDNA.
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MATERIALS AND METHODS
Cell culture and transfection.
CHO 43-3B cells (17) were routinely grown in DMEM/F1O '1:1)
medium with 5% fetal calf serum and antibiotics. To test for a
functional ERCC-1 gene, DNA constructs (5-10 jg) were
cotransfected with pSV3gptH (2-5 ug) to 5.105 43-3B cells in
three 9 cm dishes as described previously (8). After 10-14 days
of selection on mycophenolic acid (MPA) and MMC the cells were
fixed, stained and clones were counted.
Unscheduled DNA Synthesis.
Two days after seeding in medium without MPA and MMC the cells
were exposed to UV light (16 J/m2) and incubated in thymidine-
free, Ham's F10 medium supplemented with 3H-thymidine (10 uCi/ml;
specific activity 50 Ci/mmol) and 5% dialyzed fetal calf serum
After Bouin fixation the preparations were processed for
autoradiography (Kodak AR10 stripping film), exposed for 1 week
at 40C, developed and stained with Giemsa solution. For each
preparation the number of grains per fixed square of 50 nuclei
was counted.
RNA preparation and Northern blotting.
Total RNA was isolated from adult mice (Balb C), size
fractionated on 1% agarose gels and after transfer to
nitrocellulose filters hybridized to mouse ERCC-1 cDNA probes
following standard procedures (18). Probes were labeled using the
random primer technique (19).
cDNA cloning
A mouse brain cDNA library was prepared in phage AgtlO and
screened with a human ERCC-1 cDNA probe as reported earlier (20).
Plasmid Constructions and Sequencing.
Routine protocols were used for plasmid isolation, subcloning and
ligation (18). Nucleotide sequences were determined by the
chemical cleavage (21) or chain termination method (22).
Oligonucleotides for specific priming and Tab-linker mutagenesis
were made with an Applied Biosystems DNA synthesizer. Human and
mouse ERCC-1 cDNA plasmids were constructed as follows:
PTZME. Both EcoRI inserts of AgtlO mouse ERCC-1 cDNA were
subcloned in pTZ19R (Pharmacia) yielding pM4a-2, harboring the 5'
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cDNA part and pM4a-1 containing the remaining 3' half. The
artificial 5' EcoRI site of pM4a-2 was removed by very short
Bal3l treatment starting from the adjacent SstI site in the
polylinker. The retained HindIII and PstI site of the polylinker
were used to insert the HindIII-PstI fragment of pcDX (23)
harboring the SV40 early promoter. Finally the EcoRI fragment of
pM4a-1 was subcloned behind the 5 cDNA part yielding pTZME.
pcDEMP1 and pcDEMP2. The 0.42 kb SmaI fragment of human ERCC-1
cDNA clone pcDE (14) was subcloned in pSP65 in which the unique
PstI site was deleted giving pSPSma. This plasmid was linearized
with PstI or KpnI (unique ERCC-1 cDNA sites) and 0.5 tg ligated
overnight at 40C to 4 pg of either a PstI-Tab linker (5' GCTGCA
3') or a Kpn Tab-linker (5' GCGTAC 3') in 10 il (24). After
ethanol precipitation (to eliminate excess unligated linker) the
DNA was kinased and ligated to generate circular molecules. The
insertion of a single Tab-linker in PstI and KpnI site was
confirmed by sequence analysis. The PstI and KpnI mutated inserts
of pSPSma were subsequently recloned in pcDE yielding pcDEMP-1
and pcDEMP-2 respectively.
pcDEBgl. pcDE (14) was digested with BglII, treated with Klenow
DNA polymerase to create blunt ends and religated.
pcDEASt. The StuI fragment of pcDE was deleted by StuI digestion
and religation yielded pcDEAStu with a single StuI site and ERCC-
1 sequences 3' of codon 214 (14). Construct pcDEAStu was
linearized by StuI/AvaI double digestion which releases a + 60 bp
StuI-AvaI fragment. After klenow treatment to fill in the AvaI
site the earlier deleted StuI fragment was inserted again
yielding pcDEASt.
RESULTS
Characterization of mouse ERCC-1 cDNA.
Southern blot hybridization with DNA digests of various
vertebrates indicated that the ERCC-1 cDNA was strongly conserved
in evolution. Under reduced stringency conditions specific
hybridization was found with mammalian, reptile, avian and fish
DNA and very weakly with DNA of Drosophila (data not shown)
whereas no hybridization was found with DNA from Trypanosomes,
yeast and E.coli . This indicated that it should be possible to
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isolate the mouse ERCC-1 cDNA from a mouse library using human
ERCC-1 probes. A full length mouse ERCC-1 cDNA clone (designated-
AcDME) was isolated from a brain AgtlO cDNA library using human
ERCC-1 cDNA as a probe. To establish whether this clone encoded a
functional ERCC-1 protein the cDNA insert of AcDME was released
with EcoRI, subcloned in a SV40 based mammalian expression
cartridge (see Materials and Methods) and transfected to CHO 43-
3B cells. The results of this experiment, in which human ERCC-1
cDNA construct pcDE (14) served as a positive control, are shown
in Table 1. Using the mouse ERCC-1 cDNA construct pTZME, stable
MMC resistant transformants could be generated with a
transfection frequency (not shown) similar to pcDE. Furthermore,
mouse cDNA transformants displayed levels of unscheduled DNA
synthesis (UDS) in the wild type range (see Table 1), indicating
that the isolated mouse cDNA harbors a functional ERCC-1 gene.
The complete nucleotide sequence of AcDME and predicted amino
acid sequence are given in Figure 1. The mouse ERCC-1 cDNA
appears to encode a protein of 298 amino acids and deduced
molecular weight of 32970 Dalton. The alignment of the mouse
ERCC-1 protein with its human homologue, the postulated
functional domains (12) and the homology with the yeast RAD10 and
TABLE 1
Test for functional mouse ERCC-1 gene.
Cell line Transfected DNA MMC resistant UDS*)
clones
43-3B pcDE + 25 + 1
43-3B pTZME + 27 + 1
43-3B -DNA 6 + 1
CHO-9 19 + 1 *)
HeLa 33 + 1 )
expressed as average number of grains (+SEM)
per fixed square in 50 nuclei.
UDS of untransfected cells.
Mouse ERCC-1 cDNA was constructed behind the SV40 early promoter
(yielding pTZME) and cotransfected with pSV3gptH to 43-3B cells
followed by selection on mycophenolic acid and mitomycin-C (MMC).
To substantiate repair proficiency of transformants UV-induced
unscheduled DNA synthesis (UDS) was determined.
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5' GAGTCTAGCAGGAGTTGTGCTGGCTGTGCTGGCGTTGTGTCGCCTCTGTTTCCCCCCGTGGTATTTCCTTCTAGGCATCGGGAAAGACCAGGCCCCAG
1 50
MetAspProGlyLysAspGluGluSer Ar gProGlnProSerGlyPr oPr oThrArgAr gLysPheVal IleProLeuGluGluGluGluVa lProCysAlaGlyValLysProLeuPhe
AT,GGACCCTGGGAAGGACGAGGAAAGTCGGCCACAGCCCTCAG GACCACCCA,CCAGGAGGAAGTTTGTTATCCC ACTGGAGGAAGAAGAGGTGCCCTGTGC A,GGGGTCAAGCCCTTATTC
100 150 200
41
ArgSer Ser ArgAsnProThr IleProAlaThr SerAlaH isMetAlaPr oGlnThr TyrAlaGluTyrAlaI leThrGlnProPr oGlyGlyAlaGlyAlaThrVa lProThrGlySer
AGATCGTCACGGAATCCCACCATCCCAGCAAC,CTCAGCCCACATGGCCCCTCAGACGTATGCTGAGTACGCCATCACCCAGC,CTCCAGGAGGGGCTGGGGCCACAGTGCCCACAGGCTCT
250 300
81
GluProAlaAlaGlyGluAsnProSerGlnThrLeuLysThrGlyAlaLysSerAsnSer IleIleValSerProArgGlnArgGlyAsnProValLeuLysPheValArgAsnVaPro
GAACCTGCGGCA,GGAGAGAACCCCAGCCAGACCCTGAAAACAGGAGCAAAGTCTAATAGC(:AT,CATCGTGASGCCCGAGGCAGAGGGGCAACCCCGTGTTGAAGTTTGTGCGCA,ATGTGCCC
350 400 450
121
Tr pGluPheGlyGluVal1I leP roAspTy rValLeuG lyGl nSe rTh rCy sAlaLeuPheLeuSer LeuAr gTyr H isAsnLeuH isP roAspTy r IleHi sGluArgLeuGlnSe rLeu
TGGGAATTCGGTGAGGTGATTCCCGATTATGTGCTGGGCCAG,AGCACCTGCGCCCTTTTCCTCAGCCTCCGCTACCACAACCTCCATCCAGA,CTACAT CCATGAACGGCTGCAGAGCCTG
500 550
161
GlyLysAsnPheAlaLeuAr gValLeuLeuVa lGl nValAspVa lLysAspPr oGlnGl nAlaLeuLysGluLeuAlaLysMe tCys IleLeuAlaAspCy sThr LeuVa lLeuAlaTr p
GGGAAGAACTTCGCCCTTCGTG,TGCTGCTGGTTCAAGTGGATGTGAAAGATCCCCAGCAGGCTCTCAAGGAG,CTGGCTAAGATGTGCATCTTGGCTGACTGCACCCTGGTCCTGGCCTGG
600 650
201
SerAlaGluGluAlaGlyAr gTy rLeuG luTh rTy rAr gAlaTy rGluGl nLysP roAlaAspLeuLeuMe tGl uLysLeuGluGl nAsnPheLeuSer Ar gAlaTh rGluCysLeuTh r
AG,TGCAGAGGAAGCAGGGCGGTACCTGGAGACCTACAGGGCGTATGAGCAGA,AGCCAGCCGACCTCCTTATGGAAAAGCTGGAGCAGAACTTCCTATCACGG,GCCACTGAGTGTCTGACC
700 750 800
241
ThrValLysSerVa lAsnLysThr AspSer GlnThr LeuLeuAlaThr PheGlySer LeuGluGlnLeuPheThrAlaSerAr gG luAspLeuAlaLeuCysPr oGlyLeuGlyPr oGln
ACCGTGAAATCTGTGAACAAGACCGACAGCCA,GACCCTCCTGGCTACATTTGGATCCCTGGAACAGCTCTTCACCGCATCAA,GGGAGGATCTAGCCTTATGCCCGGGCCTGGGCCCACAG
850 900
281
LysAlaArgArgLeuPheGluValLeuHisGluProPheLeuLysValProArg***
AAGGCCCGCAGG,CTCTTTGAAGTACTACACGAACCCTTCCTCAAAGTGCCTCGATGACCTGC,TGCCACCTAGGCCCATGTCACAATAAAGAATTTTCCATGCCCAGAAAAAAAAA 33
950 1000 1050
Figure. 1.
Nucleotide sequence and translated amino acids (in three letter
code) of the mouse ERCC-1 cDNA. Amino acids are numbered on the
left and nucleotides are numbered below the sequence. The
polyadenylation signal AATAAA is underlined.
E.coli uvrA and uvrC repair proteins is shown in Figure 2A.
Despite the differences between both mammalian proteins their
extent of homology with the yeast and bacterial proteins is
comparable. The positions of the conserved and non-conserved
amino acid changes between the mouse and human protein are
schematically depicted in Figure 2B. The overall homology between
both proteins is 85%. However, it is striking that the majority
(>70%) of the amino acid and nucleotide substitutions are concen-
trated in the N-terminal part of ERCC-1. Of the first 100 amino
acids 70% are homologous whereas the region from 100 to 200 and
200 to 298 have similarities of 97% and 89% respectively. Two
amino acid changes are found in the postulated NLS domain, 3 in
the suggested ADP-monoribosylation site and none in the potential
DNA-binding domain. The 2 conservative substitutions in the NLS
(Ala- -Thr and Lys- -Arg) are at positions which have been shown
not to be critical in the SV40 T-antigen NLS (25). Therefore
these changes are not expected to abolish a potential NLS
function of this domain. The high degree of sequence conservation
in the putative DNA-binding domain supports the idea that this
part of the protein is very important for its function and cannot
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A 1
RAD10: MNNTDPPTSF [E IfL A GV FK'L-EKSGA TGSQS:LtE IDAjS]KLQQQEFP1Q
H-ERCC-1: MPGKDKEaVPQPSGPPARI KKFVIPLDEIDEVPPGVAKPLFRIS
M-ERCC-1: - --- - - iE,--- ------
_S I[PIA.
50 1 00 50
RAD10 :TS RRINSNQVI NAFN QKPEE W DSKA,T13DYNRK RPF1_RsrT.RP K rVLV K2EfNPLL
H-ERCC-1:jTSAQAAPQTYAEYA IS PLEGAGATCPTGfSE,PLAGETPNQAL4'KPG AKSNSIISPR RkGNPV
M-ERCC-1:__ HUM-------- T -PG---- ------ --- _S -T:-
_ -
1 5 0RA1 LfeS T N[W S TG I NMKI.Y YD fV-RG RS V-L TTKq'YV S R|MP S;ki E N N'I -L I:FRAD10 : tK MTNRYV DY
H-ERCC-1:F;VR-NV E F D :V.-IPDYV G SCALF LSL NHP DYHGRL S G:K N FAL R'V L VM-ERCC-1:- E_._----------- ----- - -E- - ------
2 0 DNA-BD 1r50
RADIO :IV DNNSEDT NNDI:,TKLjMFNGF L >FNFAQKA APRS
H-ERCC-1: V KDPQQALK:EtGAIKIMCILADCT LILAWSP EAGYLE YKAE QKAPA DL| KL,E QvDVS R:M-ERCC-1:-11-V- -- - -
------
-:---- ----V-- -Y --AA--S-|-- ~--,- P- -- |---,- !- -N1 N ,LuvrA
~~~~~~~~~~~~~~20 0 WGQRVES.LS A, F L S|L MHEKI.D,J-IE GL.uvrA EGQRRYVE LSE K
50
540 588
uvrC :[TSS E._GITSQGLAE1KI~f WSLK.H*
tETY PKRRMLLKMaGDRA SVE AKV FWSR
H-ERCC-1:ITIECLTT:KSVNKTDSIOTILL~TTFGSLELIAASREDLALCPG LOGPQKIAIRLF~DVLHEEPFLKVP*
M4-ERCC-1: !!---- -L -- --A -- -FT - -[ -- jE --K. R
uvrA :: SP A-:SIEQjKS
90
B
ITi,ni E1 T 1 ITIt I I TI rl TI T
H2N COOH
NLS 100 DNA-BD 200 ADP-RS
t CONSERVATIVE| NON-CONSERVATIVE] ACIDS
Figure. 2.
A: Alignment of mouse (N) and human (B)
one letter code) with yeast RAD10 and parts of
uvrC proteins. Of the mouse protein (horizontal
differences with human ERCC-1 are depicted. Identical
are boxed with solid lines and physico-chemically
residues (K, R; D, E and V, I, L) are indicated
between the microbial and mammalian proteins.
postulated domains (12) are shown by black
location signal; DNA-BD, DNA binding domain;
monoribosylation site. Asterisks indicate stopcodons. RADIO,
H-ERCC-1, uvrA and uvrC amino acid sequence
described (14, 41, 42, 43 respectively).
B: Schematical presentation of conserved and
acid changes in mouse and human ERCC-1 protein.
acids are grouped as follows: A,S, T, P and G;
R and K; M, L, I and V; F, Y and W. The postulated
and ADP-RS are depicted as boxes (see also Fig.2A).
region corresponds to human exon VIII which
to be subject to alternative splicing
tolerate many amino acid alterations. The 2
acid changes in the region to which we have tentatively
an ADP-monoribosylation site are at positions
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with such a function. However, the non-conservative substitution
at position 235 (Val-.-Ala) neighbours the arginine residue that
is the actual site of ADP-ribosylation by cholera toxin in the
consensus sequence of this domain (26). Hence, the difference
between the mouse and human protein at this position makes it
less likely that ADP-monoribosylation plays an important role in
ERCC-1 protein processing.
At the nucleotide level the similarity of the coding regions of
mouse and human ERCC-1 is 82% and of all base changes 70% are at
'wobble' base positions. With respect to the 5' untranslated
region it is worth noting that at position -3 upstream of the
translation initiation site a conserved C-residue is located
which is highly exceptional for eukaryotic mRNAs (27).
Partial characterization of the mouse ERCC-1 promoter region.
The mouse ERCC-1 gene was isolated from a genomic EMBL-3 library
using mouse cDNA as a probe. Four overlapping EMBL-3 clones,
shown in Figure 3, hybridized to 5' and 3' cDNA probes (not
shown) indicating that the mouse ERCC-1 gene has a maximum size
of 16-17 kb which is comparable to the previously reported size
of the human ERCC-1 gene (28). In order to determine the mouse
ERCC-1 promoter sequence a 0.9 kb HindIII-BamHI fragment
hybridizing with a 5 cDNA probe was subcloned in pTZ19R,
yielding pMHB5. The sequence strategy of this clone, depicted in
Figure 3, revealed genomic sequences that were completely
identical to the cDNA sequence (Figure 1). Moreover, it was found
that the genomic organization of mouse ERCC-1 exon 2 is similar
to that of the human gene (not shown). A comparison of the mouse
5' genomic and untranslated cDNA sequence with the corresponding
human sequence (28) is presented in Figure 4. A long stretch of
homologous nucleotides is found around the transcriptional start
site of the human gene (box A, Figure 4), which makes it likely
that transcription of the mouse ERCC-1 gene initiates at the
corresponding position in box A. This means that deletions or
insertions rather than nucleotide substitutions have mainly
contributed to the differences in the mouse (113 nucl.) and human
(153 nucl.) 5' untranslated regions. We previously showed that
the ERCC-1 promoter is located within 170 bp upstream of the
transcriptional start site (28). Like the human ERCC-1 promoter
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_____ __I_*___.__*_ 5A
4A
- p H I
_____________- - - - ~~3.1
0.2KB _
5 3'
_--4'4*~'MOUSE ERCC-1 GENE
Figure. 3.
Isolation of the mouse ERCC-1 gene. Physical maps are shown of 4
overlapping clones that were isolated from a genomic EMBL-3
library. The position of the ERCC-1 gene (shaded bar) was
deduced from hybridization with cDNA probes. Not all restriction
sites are given. Non-characterized flanking parts are shown as
dashed lines. The 5' EcoRI-BamHI fragment was studied in detail
and sequenced as shown by arrows. Exon I and II are indicated as
black boxes. Restriction sites: E, EcoRI; B, BamHI; H, HindIII;
P, PstI.
the mouse promoter is lacking clearly identifyable CAAT and TATA
boxes as well as GC-rich regions. However, at 60 to 70 bp
upstream of the 'cap'-site a domain of 30-40 bp (box B, Figure 4)
is coinciding with a region in the human promoter which harbors
three CCTCC pentanucleotides that are each spaced by 5
nucleotides. The conservation of this region suggests that it has
MOUSE
HUMAN
_--lQQ- ______ -ao D -60 -40
5 AAGCTTCCATCCGCCCCAAACCACAGCGGTCCTCCAGGACCATAGAGAGCAGCGCGAATAGAGTTCCCCGCTCTA------ACTCCTCCGGG
* I* *** *** *** ***** *******l * * * * * *** ****** *** **5'ACATCTCTCTCCTCCCACGACCTCCGCGGTCCTCCAGAACCATAGAGAGTTGTACAGAGATCG--CCCTGCTCTATGCTCTACTCTCCTGGG
-80 -60 -40 -20
-20 1 A rDNA20 40 60MOUSGACAGGAGCGACGAAGGCAGA-GGCGGAGTGGTCAGCGGA-TG-- CT---------- GTGT-T--------- CCMOUS*EGAGCAGCGAGACGAGCGAAIGGGCCAGAG-GGCCGGAAGTGTCTAGCAGGAGTTGT -GCTGGCTGTGCTGGCGTTGTGTCGCCTCTGTTTCCC
HUMAN GAGC--------------GGGGCCAGAGAGGCCGGAAGTG-CTGCGAGCCCTGGGCCACGCTGGCCGTGCTGGCAGTGGGCCGCCTCGAT--CCC
1 20 40 60
80 100
MOUSE CCCGTGGTATTTCCTTCT--------------------- AGGCATCG------GGAAA------------ GAC--CAGGCCCCAGATG
* ***** **** *** **** *** *********
HUMAN TCTGCAGTCTTTCCCTTGAGGCTCCAAGACCAGCAGGTGAGGCCTCGCGGCGCTGAAACCGTGAGGCCCGGACCACAGGCTCCAGATG
80 100 120 140
Figure. 4.
Alignment of 5' mouse and human ERCC-1 sequences upstream of the
translational start site (ATG). The mouse sequence is a
compilation of genomic and cDNA (Fig. 1) sequence. The human
sequence is from Van Duin et al. (14, 28). Boxes A and B show the
most conserved regions in the ERCC-1 promoter. Nucleotide
numbering is based on transcriptional start site ( A ) of the
human gene. Gaps are introduced to improve alignment of both
sequences.
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a regulatory function for ERCC-1 transcription. We have screened
the EMBL sequence data base for nucleotide sequences homologous
to box B, however, no apparent homology turned up.
Expression of ERCC-1 in mouse organs and developmental stages.
To examine possible regulatory aspects of the ERCC-1 promoter,
ERCC-1 expression was investigated by Northern blot analysis of
various mouse organs and stages of development. As a control for
differences in the amount of RNA the blot was rehybridized with
with a probe for the GAPDH mRNA which is considered to be present
in relatively constant amounts and has a size very close to that
of ERCC-1. As is shown in Figure 5 ERCC-1 transcripts could be
detected in all organs (including also liver, stomach, bonemarrow
and thymus, not shown) and stages of development examined. The
differences in hybridization signal in the different lanes are to
a large extent also observed with the GAPDH probe and therefore
reflect mainly variation in the quantity of RNA on the filter.
From comparison of the hybridization intensities of ERCC-1 and
those of other genes (e.g. GAPDH and actin) we infer that ERCC-1
RNA falls in the class of low abundant messengers. Furthermore,
in situ hybridization experiments on sections of mouse embryo's
did not reveal tissues with a specific high level of ERCC-1
expression (not shown). These results support the conclusion that
ERCC-1 is equally expressed at low levels throughout the whole
body and at various stages of embryogenesis. The ERCC-1 promoter
may thus represent a member of a novel class of promoters
specifying a constitutive low expression level.
Mutagenesis of the human ERCC-1 cDNA.
A number of mutant human ERCC-1 cDNAs were constructed (see
Materials and Methods) and transfected to CHO 43-3B cells to test
for functionality. The results of these experiments are
summarized in Figure 6. Construct pcDE-72 is included as negative
control, since this clone lacks the alternatively spliced exon
VIII which is essential for phenotypic complementation of the
mutation in CHO 43-3B cells (14). Similarly all other alterations
induced in the C-terminal portion of ERCC-1 appear to be
deleterious as well. Construct pcDEASt, that encodes a 'RAD10-
like' ERCC-1 protein terminating exactly at the point where (the
homology with) the RADiO gene product stops (see Figure 2A) does
5314
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Figure. 5.
Northern blot analysis of mouse organs. Equal amounts (20 jg) of
total RNA was size fractionated on a 1%3garose gel and after
transfer to nitrocellulose hybridized to P-labeled mouse ERCC-1
cDNA (upper part) and a probe for the glyceraldehydephosphate
dehydrogenase (GAPDH, 44; lower part). The position of ribosomal
subunits and ERCC-1 and GAPDH transcripts are indicated on the
left.
not display detectable correcting activity. The same holds for
construct pcDEBgl which encodes a truncated protein of 287 amino
acids with 17 unrelated C-terminal residues due to a frameshift
mutation. These findings are in striking contrast to deletion of
the N-terminal ERCC-1 region. We reported previously that a
truncated protein lacking the first 54 amino acids (encoded by
construct pcD3C) is still able to confer MMC resistance to CHO
mutant cells (14). Tab-linker mutagenesis (24) was applied to
insert 6 nucleotides in the unique PstI and KpnI site in the
coding part of the human ERCC-1 cDNA. The resulting introduction
of a leucine and glutamine behind the putative DNA-binding domain
(residue 158; construct pcDEMP1) did not affect the repair
5315
Nucleic Acids Research
CONSTRUCT ERCC-1 PROTEIN CORRECT ION OF
PcDE * _ 1(297) +
PcDE72 I * I (273) -
PcD3C (266) +
PcDEMP1
PcDEMP2
PCDEBGL
_
_nr AO
* _. ](299)
ALeu GIn
I _m 1(299)
AlaoTyr
* _m 0.1. (287)
+
PC1JLAST - (2 1 5) -
NLS DNABD
Figure. 6.
Mutagenesis of the ERCC-1 gene. SV40 early promoter driven ERCC-1
cDNA constructs were cotransfected with pSV3gptH to CHO 43-3B
cells, to test for a functional gene. Stable transformants were
selected on mycophenolic acid and MMC. Construct pcDE, harboring
the complete human ERCC-1 cDNA, served as a positive control.
pcDE-72 and pcD3C have been described previously (14) and encode
proteins that are lacking 24 amino acids encoded by exon VIII and
the first 162 coding nucleotides respectively. The other
constructs are described in Materials and Methods. Putative
functional domains (nuclear location signal, NLS; DNA-binding
domain, DNA-BD) that emerged from human and mouse ERCC-1 amino
acid comparison are depicted as black boxes. Unrelated amino acid
sequences due to frame shifts are shown as dotted areas. Amino
acid number is given in parentheses.
function of ERCC-1 in CHO mutants whereas an extra alanine and
tyrosine residue distal from amino acid 208 (construct pcDEMP2)
inactivated the protein. In conclusion the data presented here
are consistent with the notion that the C-terminal part is
crucial for ERCC-1 function in contrast to the N-terminus.
DISCUSSION
The complex evolution of the human ERCC-1 gene, resulting in a
'mosaic' type of homology to repair proteins of lower organisms
has prompted us to study the gene in other species. Here we
describe the isolation and characterization of cDNA and genomic
clones of mouse ERCC-1. Transfection of the mouse ERCC-1 cDNA to
43-3B cells conferred UV- and MMC resistance and restored UDS.
The induction of a UDS level inbetween that of CHO9 wild type and
HeLa cells was also found after transfection of the human ERCC-1
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gene and cDNA (8). The finding that UDS is higher in corrected
43-3B cells compared to wild type CHO cells can be explained by
differences in nucleotide poolsizes, cell morphology and other
factors influencing UDS. Alternatively, it is not excluded that
transfected ERCC-1 genes from human and mouse induce a higher UDS
level then the endogenous CHO gene.
Southern blot and sequence analysis of mouse genomic clones
indicate that the mouse and human gene are similar in size.
Preliminary data also suggest a very similar gene organization.
The ERCC-1 gene of both mouse and man is driven by an exceptional
promoter lacking 'classical' promoter elements. Comparison of the
mouse and human promoter region revealed a highly homologous
sequence at 50 to 90 bp upstream of the transcriptional start
site. We have not noticed this putative promoter motif in other
genes The high sequence conservation suggests that ERCC-1
expression is mediated through interaction of transcription
factors with this region. However, additional experiments,
including 'footprinting' are required to verify this assumption.
In HeLa cells ERCC-1 expression appears to be constitutive and
not inducible by UV and MMC (28). We present here that ERCC-1 is
transcribed at low levels in all mouse organs and stages of
development investigated. Also Northern blot analysis of a number
of different human cell lines revealed low constitutive levels of
ERCC-1 expression (not shown). Therefore ERCC-1 is probably not
only operative in repair of environmentally induced DNA-damage
(e.g. UV photo products) but perhaps more importantly in the
removal of DNA injuries that are induced at a constitutive rate
in all cells and tissues by various intracellular processes.
With respect to ERCC-l expression at the protein level it is
worth noting that rodent and human ERCC-1 mRNAs have a C-residue
at position -3 proximal to the translation initiation site. More
than 95% of eukaryotic messengers harbor a purine at that
position (27) and mutation studies have demonstrated that this
dramatically enhances translation efficiency (29, 30). Although
the presence of a G-residue at position +4 in the ERCC-1
transcripts might partially compensate for the lack of a purine
at -3 (27) it seems likely that &RCC-1 has a conserved low
translational efficiency. Yeast DNA excision repair genes also
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belong to a category of lowly expressed genes (both at RNA and
protein level) as deduced from codon usage and translation
initiation consensus (31, 32). It will be of interest to see
whether the recently isolated human repair genes XRCC-1
(L.Thompson, pers. comm.) and ERCC-2 (9) are subject to the same
mode of translational control.
The cloning and sequence analysis of the mouse ERCC-1 gene has
yielded instructive information that can be used to elucidate the
function of the protein. Comparison of mouse and human amino acid
sequences shows that the N-terminal protein part is much less
conserved than the rest of the protein. This is in accordance
with the pattern of similarity with the yeast RADIO protein,
which showed a high level of homology in the middle part of ERCC-
1 (corresponding with the C-terminal half of RAD10) but only
barely detectable similarity between the N-termini of both
proteins. The apparent reduced evolutionary pressure for sequence
conservation of the 5' portion of ERCC-1 fits also nicely with
the transfection results of the 'decapitated' cDNA construct
pcD3C (Figure 6) which demonstrated that a large N-terminal
segment can be omitted without affecting the correcting potential
of the ERCC-1 protein. This underlines the idea that ERCC-1 and
the yeast RADIO protein operate in a related step in the
intricate excision repair process.
Notwithstanding this extensive homology, one important difference
remains between the mammalian and yeast protein: a C-terminal
extension of ERCC-1, which appears to be essential for proper
functioning of the protein in CHO cells. The finding of this
region in the mouse ERCC-1 protein indicates that it was present
before the evolutionary lines to mouse and man diverged (65-80
million years ago).
Which evolutionary events may have caused the remarkable
difference with the yeast gene? It is not excluded that a
primordial ERCC-1 gene has lost its C-terminus to generate a
RAD10-like version. Alternatively, C-terminal sequences might
have been added to an ancestral RADIO-like gene yielding the
ERCC-i-like gene structure. The fact that the extra region of
ERCC-1 displays homology with prokaryotic repair proteins may be
the result of convergent evolution. Another interesting
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possibility is that the ERCC-1 gene has acquired functional
domains from prokaryotic genes that originally resided in
mitochondrial DNA but have migrated to the nucleus in the course
of evolution. We are currently trying to isolate the Drosophila
ERCC-l/RAD10 homologue which will hopefully shed more light *on
the evolution of ERCC-1.
Evolution has provided mouse ERCC-1 with one extra C-terminal
amino acid compared to the human protein. Despite this minor
difference our mutation studies indicate that the C-terminal part
of ERCC-1 seems to be very important for its repair function.
This region of ERCC-1 displays significant homology with the C-
terminus of the E.coli uvrC protein (13). Interestingly, it
appears that a mutation in this part of uvrC also leads to
inactivation (33). Taken together these data support the idea
that ERCC-1 and uvrC share a similar important function.
Several nuclear proteins are provided with positively charged
domains that direct active transport through the nuclear membrane
(34-38). A consensus sequence for this nuclear location signal
(NLS) has emerged from detailed studies of Kalderon et al. (24,
38) and Colledge et al. (39). Amino acids 16 to 23 are conserved
between mouse and man and show structural homology with a SV40 T-
antigen NLS (12). It is therefore somewhat unexpected that the N-
terminal ERCC-1 part appears to be non-essential. However,
several explanations can be put forward for this observation.
First, the size of the truncated ERCC-1 protein should allow it
to enter the nucleus also by passive diffusion (40). Although
probably less efficient, this process might still ensure
sufficient ERCC-1 levels in the nucleus to permit correction of
the CHO 43-3B mutation. In this context it should be realized
that cDNA transformants in general have integrated multiple
copies of the ERCC-1 cDNA constructs. Moreover, the cDNA inserts
are driven by a SV40 promoter which is expected to accomplish a
much higher expression level than the promoter of the unique
endogenous ERCC-1 gene. Secondly, it is possible that N-terminal
truncated ERCC-1 proteins can only be functional in rapidly
dividing cells in culture in which the nuclear membrane is
frequently absent, allowing the decapitated ERCC-1 protein to
'sneak in'. Therefore one could speculate that a deletion like in
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cDNA construct pcD3C would be more serious in non-proliferating
tissues in vivo. Finally, it cannot be excluded that ERCC-1 is
harboring a second NLS of another type as has been found for
polyoma virus large T (34) and the glucocorticoid receptor (35).
Currently experiments are underway to investigate the
hypothesized NLS in more detail.
Purification of the ERCC-1 protein will be an important
prerequisite for studying the function of ERCC-1. The results
presented in this paper demonstrate that such studies benefit
from detailed analysis of evolutionary related genes.
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At the recent UCLA meeting on 'Mechanisms and Consequences of
DNA damage processing ' in Taos (january 1988) it was decided to
renumber the CHO excision deficient complementation groups 1 and
2 to match with the number of the human ERCC-genes correcting
their respective defects: ERCC-1, group 1 (formerly group 2);
ERCC-2, group 2 (formerly group 1).
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